PL448929A1 - Nowe (kumaryno-7-amino)-acetamidy oraz ich zastosowania - Google Patents
Nowe (kumaryno-7-amino)-acetamidy oraz ich zastosowaniaInfo
- Publication number
- PL448929A1 PL448929A1 PL448929A PL44892924A PL448929A1 PL 448929 A1 PL448929 A1 PL 448929A1 PL 448929 A PL448929 A PL 448929A PL 44892924 A PL44892924 A PL 44892924A PL 448929 A1 PL448929 A1 PL 448929A1
- Authority
- PL
- Poland
- Prior art keywords
- group
- amino
- zastosowania
- kumaryno
- acetamidy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia są pochodne (kumaryno-7-amino)-acetamidy o wzorze 1, gdzie R1 oznacza grupę trifluorometylową, metylową lub atom wodoru, R2 oznacza atom wodoru, grupę 1-fenylopropano-2-on lub 5-okso-pentanowego kwasu, R3 oznacza podstawioną lub niepodstawioną grupę fenylową, benzylową, R4 oznacza prostą lub rozgałęzioną grupę alkilową o C1-C8, podstawioną lub niepodstawioną grupę fenylową, benzylową, sposób ich wytwarzania, zawierające je kompozycja farmaceutyczna oraz ich zastosowanie do otrzymywania leków w leczeniu stanów zapalnych w ośrodkowym układzie nerwowym, wywołanych przez bakterie patogenne związane ze wzmożoną proliferacją komórek.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL448929A PL448929A1 (pl) | 2024-06-21 | 2024-06-21 | Nowe (kumaryno-7-amino)-acetamidy oraz ich zastosowania |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL448929A PL448929A1 (pl) | 2024-06-21 | 2024-06-21 | Nowe (kumaryno-7-amino)-acetamidy oraz ich zastosowania |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL448929A1 true PL448929A1 (pl) | 2025-12-22 |
Family
ID=98212022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL448929A PL448929A1 (pl) | 2024-06-21 | 2024-06-21 | Nowe (kumaryno-7-amino)-acetamidy oraz ich zastosowania |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL448929A1 (pl) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL353245A1 (pl) * | 1999-09-03 | 2003-11-03 | Indena S.P.A. | Kumaryny chalkonowe |
| PL407948A1 (pl) * | 2014-04-18 | 2015-10-26 | Instytut Chemii Organicznej Polskiej Akademii Nauk | Nowe pochodne kumaryny, sposób ich wytwarzania oraz ich zastosowanie w sposobie wykrywania i/lub oznaczania aktywności katalitycznej i stereoselektywności reakcji hydrolaz |
-
2024
- 2024-06-21 PL PL448929A patent/PL448929A1/pl unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL353245A1 (pl) * | 1999-09-03 | 2003-11-03 | Indena S.P.A. | Kumaryny chalkonowe |
| PL407948A1 (pl) * | 2014-04-18 | 2015-10-26 | Instytut Chemii Organicznej Polskiej Akademii Nauk | Nowe pochodne kumaryny, sposób ich wytwarzania oraz ich zastosowanie w sposobie wykrywania i/lub oznaczania aktywności katalitycznej i stereoselektywności reakcji hydrolaz |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8306726A1 (es) | "procedimiento para la preparacion de derivados de benzazepina". | |
| PT880508E (pt) | Derivados de quinazolina como inibidores de vegf | |
| PT1412354E (pt) | Derivados de triazolil-imidazopiridina e de triazolilpurinas uteis como ligandos do receptor a2a da adenosina e sua utilizacao como medicamentos | |
| EA200100486A1 (ru) | Производные 2-уреидотиазола, способ их получения и применение указанных веществ в качестве противоопухолевых средств | |
| AR032436A1 (es) | Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro | |
| ATE316961T1 (de) | Heterozyclische derivate für die behandlung von herzversagen und andere erkrankungen | |
| TN2010000026A1 (fr) | Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met | |
| MEP25608A (en) | Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics | |
| EE9700282A (et) | Bensimidasooli ühendid, nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine | |
| NO942304D0 (no) | Nye fosfonoravsyrederivater, fremgangsmåte for fremstilling derav, samt legemiddel inneholdende derivatene | |
| HUP0100558A2 (hu) | S-Oxid- és S,S-dioxid-tetrahidrotiopirán-fenil-oxazolidinon-származékok, e vegyületek alkalmazása gyógyászati készítmények előállítására, valamint eljárás e vegyületek gátló hatásának meghatározására humán-monoamin-oxidázzal szemben | |
| BR0015195A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas | |
| BR0308780A (pt) | Composto, processo para a preparação e uso do mesmo, método para o tratamento de um sujeito humano ou animal que sofre de, ou que é suscetìvel a, uma condição inflamatória, e, composição farmacêutica | |
| BR9306221A (pt) | Derivados do acilaminoindol como agonistas 5-htl | |
| ATE241607T1 (de) | Epoxybernsteinsäureamid-derivate | |
| PL448929A1 (pl) | Nowe (kumaryno-7-amino)-acetamidy oraz ich zastosowania | |
| MA29258B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| HUP9904210A2 (hu) | Kamptotecin-analógok, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| BR0115454A (pt) | Composto de 1-metilcarbapenem ou um sal ou derivado de éster deste farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto ou de um sal ou derivado de éster deste farmaceuticamente aceitável | |
| PT1185267E (pt) | Agentes anestesicos dermicos | |
| HUP0203275A2 (hu) | 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása | |
| BR0318533A (pt) | azolidinacarbonitrilas e seu uso como inibidores de dpp-iv | |
| ATE184593T1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
| KR910004559A (ko) | 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체 | |
| ATE214064T1 (de) | Indane-1-ol derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |